Eslicarbazepine acetate Related Products


SynZeal is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Eslicarbazepine acetate, pharmacopeial and non-pharmacopeial Eslicarbazepine acetate impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Eslicarbazepine acetate impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.

Eslicarbazepine acetate-related products are thoroughly characterized. Eslicarbazepine acetate products are supplied with detailed COA & analytical data meeting regulatory compliance. We can also provide EP/USP traceable standards based on your requirements. The supplied products are re-tested at regular intervals.

Eslicarbazepine Acetate

SZ目录编号:: SZ-E034001
CAS 号: 236395-14-5
分子式: C17H16N2O3
分子量: 296.3
投资状态: In Stock

Eslicarbazepine R-Isomer

SZ目录编号:: SZ-E034011
CAS 号: 186694-45-1
分子式: C17H16N2O3
分子量: 296.3
投资状态: In Stock

Eslicarbazepine Acetate Chiral Peak Id Mixuture

SZ目录编号:: SZ-E034012
CAS 号: NA
分子式: C15H12N2O2 : 2(C17H16N2O3)
分子量: 845.0
投资状态: Limited Stock

Eslicarbazepine Propionate

SZ目录编号:: SZ-E034013
CAS 号: 952740-36-2
分子式: C18H18N2O3
分子量: 310.4
投资状态: Custom Synthesis

10,11-Dihydro-10-hydroxy Carbamazepine-D4

SZ目录编号:: SZ-E034D01
CAS 号: 1020719-39-4
分子式: C15H10D4N2O2
分子量: 258.3
投资状态: Custom Synthesis

Eslicarbazepine D3

SZ目录编号:: SZ-E034D04
CAS 号: NA
分子式: C15H11D3N2O2
分子量: 257.3
投资状态: Custom Synthesis

Eslicarbazepine D8 Acetate (racemate)

SZ目录编号:: SZ-E034D02
CAS 号: NA
分子式: C17H8D8N2O3
分子量: 304.4
投资状态: Custom Synthesis
Rel. CAS No: 236395-14-5 (Unlabeled)

Licarbazepine-D8

SZ目录编号:: SZ-E034D03
CAS 号: 1261393-17-2
分子式: C15H6D8N2O2
分子量: 262.3
投资状态: Custom Synthesis

Eslicarbazepine Acetate Nitroso Impurity 1

SZ目录编号:: SZ-E034014
CAS 号: NA
分子式: C16H14N2O3
分子量: 282.3
投资状态: Custom Synthesis
categories